/foundation/biomed/b/weblog3/archive/2012/02/16/with-skolkovo_2700_s-5m-grant-theramab-ready-to-fight-pathologies.aspxThe Skolkovo Fund has approved a $5m grant to TheraMAB, innovation and venture news source UNOVA reports. The money will be reportedly spent on development of a medicine that can selectively modulate activity of T-lymphocytes for treating rheumatoid arthritis7.x Production